Balancing Type I Interferon Signaling in Cancer
In the evolving landscape of cancer treatment, type I interferons (IFNs) have emerged as pivotal players in modulating the immune...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In the evolving landscape of cancer treatment, type I interferons (IFNs) have emerged as pivotal players in modulating the immune...
In a groundbreaking development presented at the 15th European Breast Cancer Conference (EBCC15) in Barcelona, new evidence has emerged that...
In a groundbreaking new study, researchers have unveiled an intricate molecular mechanism by which the oncogene MYCN impedes differentiation in...
In the realm of cancer research, scientific discourse often intersects with societal beliefs, particularly concerning the impact of psychosocial factors...
In the relentless pursuit of breakthroughs in pediatric oncology, a promising frontier has emerged involving the intersection of molecular targeted...
In a groundbreaking development that promises to alter the therapeutic landscape for liver cancer, researchers have uncovered a pivotal molecular...
A groundbreaking study emerging from the University of Sherbrooke and the Research Centre on Aging in Quebec, Canada, has challenged...
Fear of cancer progression remains one of the most profound psychological challenges faced by individuals grappling with this complex disease....
Groundbreaking discoveries from Memorial Sloan Kettering Cancer Center (MSK) herald a transformative era in oncology, revealing innovative strategies to prevent...
In a groundbreaking study poised to reshape the cardiology and oncology interface, researchers have unveiled compelling evidence that N-acetylcysteine (NAC)...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine